ID W5MZ68_LEPOC Unreviewed; 1679 AA.
AC W5MZ68;
DT 16-APR-2014, integrated into UniProtKB/TrEMBL.
DT 16-APR-2014, sequence version 1.
DT 27-MAR-2024, entry version 52.
DE SubName: Full=Myomesin 1a (skelemin) {ECO:0000313|Ensembl:ENSLOCP00000013677.1};
OS Lepisosteus oculatus (Spotted gar).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Actinopterygii; Neopterygii; Holostei; Semionotiformes; Lepisosteidae;
OC Lepisosteus.
OX NCBI_TaxID=7918 {ECO:0000313|Ensembl:ENSLOCP00000013677.1, ECO:0000313|Proteomes:UP000018468};
RN [1] {ECO:0000313|Proteomes:UP000018468}
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA Di Palma F., Alfoldi J., Johnson J., Berlin A., Gnerre S., Jaffe D.,
RA MacCallum I., Young S., Walker B.J., Lander E.S., Lindblad-Toh K.;
RT "The Draft Genome of Lepisosteus oculatus.";
RL Submitted (DEC-2011) to the EMBL/GenBank/DDBJ databases.
RN [2] {ECO:0000313|Ensembl:ENSLOCP00000013677.1}
RP IDENTIFICATION.
RG Ensembl;
RL Submitted (NOV-2023) to UniProtKB.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AHAT01017653; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR STRING; 7918.ENSLOCP00000013677; -.
DR Ensembl; ENSLOCT00000013706.1; ENSLOCP00000013677.1; ENSLOCG00000011117.1.
DR eggNOG; KOG0613; Eukaryota.
DR GeneTree; ENSGT00940000154982; -.
DR HOGENOM; CLU_004753_1_0_1; -.
DR InParanoid; W5MZ68; -.
DR OMA; ECVLLMF; -.
DR Proteomes; UP000018468; Linkage group LG9.
DR Bgee; ENSLOCG00000011117; Expressed in muscle tissue and 9 other cell types or tissues.
DR GO; GO:0019900; F:kinase binding; IBA:GO_Central.
DR CDD; cd00063; FN3; 5.
DR CDD; cd00096; Ig; 1.
DR CDD; cd20951; IgI_titin_I1-like; 1.
DR Gene3D; 2.60.40.10; Immunoglobulins; 12.
DR InterPro; IPR003961; FN3_dom.
DR InterPro; IPR036116; FN3_sf.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR013098; Ig_I-set.
DR InterPro; IPR003599; Ig_sub.
DR InterPro; IPR003598; Ig_sub2.
DR PANTHER; PTHR13817:SF16; MYOMESIN-1; 1.
DR PANTHER; PTHR13817; TITIN; 1.
DR Pfam; PF00041; fn3; 5.
DR Pfam; PF07679; I-set; 4.
DR PRINTS; PR00014; FNTYPEIII.
DR SMART; SM00060; FN3; 5.
DR SMART; SM00409; IG; 6.
DR SMART; SM00408; IGc2; 5.
DR SUPFAM; SSF49265; Fibronectin type III; 3.
DR SUPFAM; SSF48726; Immunoglobulin; 6.
DR PROSITE; PS50853; FN3; 5.
DR PROSITE; PS50835; IG_LIKE; 5.
PE 4: Predicted;
KW Immunoglobulin domain {ECO:0000256|ARBA:ARBA00023319};
KW Reference proteome {ECO:0000313|Proteomes:UP000018468};
KW Repeat {ECO:0000256|ARBA:ARBA00022737}.
FT DOMAIN 231..322
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 340..447
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 461..556
FT /note="Fibronectin type-III"
FT /evidence="ECO:0000259|PROSITE:PS50853"
FT DOMAIN 589..683
FT /note="Fibronectin type-III"
FT /evidence="ECO:0000259|PROSITE:PS50853"
FT DOMAIN 690..783
FT /note="Fibronectin type-III"
FT /evidence="ECO:0000259|PROSITE:PS50853"
FT DOMAIN 895..993
FT /note="Fibronectin type-III"
FT /evidence="ECO:0000259|PROSITE:PS50853"
FT DOMAIN 1000..1099
FT /note="Fibronectin type-III"
FT /evidence="ECO:0000259|PROSITE:PS50853"
FT DOMAIN 1091..1184
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 1317..1403
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 1543..1623
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT REGION 83..111
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 833..898
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 83..106
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 833..895
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1679 AA; 187787 MW; 8CC93A1F8584382D CRC64;
MTFACSLHVH MDFCQLLQYP SKVQKHAELG TEAGPAEDSE LRSRLESLRM SSGSLPFYQK
HHRHYDRGYR STAVESTLSQ YHVEQKSSAS TRSAGLRASK YSSEESKLSP LPKRAKPTYL
AVDKDNEVIG YVVPLFRGRG EKFAYGTTDI EEAELKETAG YLGGKNVFST GQGVSLMATS
QTDTMEVERF EKKSRKVAMR ESAERIALNK KIYETEEFHK KINEDSLLHA PEFVIKPRSH
TVWEKQNVKL HCTVSGWPDP RVTWYKNNVA IDVYAHPGKY NIESRYNVHT LEINRCDFED
TAQYRASAMN AKGELSAFAS IVVKRYKGEI DDSLPVPKPP PYGLSSAYGV KFDVHIVDKF
GVSFGREGET LSLGCTVIVY PTVKLIQPEV QWYRDDVLLH PSKWVQMHWS GEQASLTLTH
LNKEDEGLYT MRVITKSGYE TYSAYVFVRD ADAEVAGAPA APLDVECQDA NKDYVIVTWK
QPAVDGGSPI LGYFIDRCEV GTTHWSQCND TPVKFARFPV TGLVEGRSYV FRVRAVNKAG
ISRTSRVSEP VAALDPADKA RMKGHPSAPW TGQIIVTEEE PAEGVVPGKP RDLAVTEATR
NYVVLSWKPP GQRGHEGIMY YVEKCVAGTD SWQRVNTEIP VKSPRFALFD LAEGKSYCFR
VRCCNSAGVG EPSEPTEATI VGDKLDIPPA PGRVLPTRNT DTSVVVSWEE SKGAKELVGY
YIEASIVGSG VWEPCNNKPV KGKRFICHGL STGQMYVLRV RAVNAAGLSQ FSQESEAIEV
KAAIGGGTPH GVWPETGDKN GGLTEHAPYW AGKHEASQPG LDTCLKSEAQ VDRHTLTPSS
DSVVPESKVS KGKGTKSISS QQKVATQQTR KSPLDGSSSQ EKTKQRRQSS ASPAPPYGIT
VLESVQDSMV LGWKQPKFIG GAEIIGYFVD YREVVDGVPG KWHEANIKAV SERAYRVNDL
KENRIYQFQV RAANVAGVGV PSKPSNSFKC EEWTIAVPGP PYELRITEVR RDSLVLLWNP
PVYQGRSEVN GFYVDIKEEH AGEEHWRSVN EKAIQNKYIK IKDLKEGTTY VFRVRAQNRA
GVGKPSDATE PVLAETRPGT KEVVVDVDDD GVISLIYECS EMTAESKFVW SKNYEGLSDL
SRLTVETKGG RSRVIFNDPS TEDLGIYSCV VTDTDGISAS YNLDEEELKR LLEISHDHKF
PTIPLKRELE VELLEKGRVR FWLQAEKMSA NGKANYVFND AILSQGEKYK MNIDRNTGIV
EMFLEKLGDE DEGTFTFQLQ DGKATNQSSL VLIGEVFKNL QKESEFQRQE WFRKQGPHFA
EYLSWEVTPE CNVLLKCKVA NILKETSIIW YKDEREIMVD NKHDFKEGVC TLLISQISKK
DAGVYEVILR DDRGKDKSSL NLTDQGFRDL MNDVFRVIAQ SATDLKIQST EEGIRLYCFV
TYYTDELRVG WHHKESKISF TDRVKSGVTG EQLWLQINEP TEKDKGKYAI EIFDGKTGVQ
KTVDLSGQAF DEAFAEFQRL KQAAIAERNR ARVVGGLPDV VTIQEGKSLN LTCNIWGDPV
PEVTWLKNER EMIQDSEHVL KFESGKFASF TITSVSSVDS GRYSILVKNK YGTECGDFTL
NVTQAFENRS MARCVADSAG NLEETMSTPD RKKKSVTGKK VQVRRGGACG HKMINIRCP
//
